Home › Companies › Elevance Health, Inc. › 2025-2026

Elevance Health, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Elevance Health, Inc.’s Form 8-K, filed May 13, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 6Ballot items
  • 1,154Asset managers
  • 7,403Fund votes
  • May 13, 2026Meeting date

Results at a glance

Meeting of May 13, 2026: 6 items on Elevance Health, Inc.’s Form 8-K, filed May 13, 2026: 3 elected · 2 approved · 1 not approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Elevance Health, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Elevance Health, Inc.

These tallies are Elevance Health, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Elevance Health, Inc. — official shareholder meeting results, meeting held May 13, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Gail K. Boudreaux 177,978,7131,714,229110,827 --14,637,570 99.0%Elected—
Elect Director: Robert L. Dixon, Jr. 174,098,4895,590,793114,487 --14,637,570 97%Elected—
Elect Director: Deanna D. Strable 175,331,8224,360,980110,967 --14,637,570 98%Elected—
2. Advisory vote on the Company's executive compensation 172,363,6167,240,619199,534 --14,637,570 96%Approved—
3. Ratification of the appointment of Ernst & Young LLP 175,183,33219,141,697116,310 ---- 90%Approved—
4. Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups 15,587,160162,924,2901,292,319 --14,637,570 9%Not approved—

Source: Elevance Health, Inc., Form 8-K, filed with the SEC on May 13, 2026 — read the filing on EDGAR.

How asset managers voted at the Elevance Health, Inc. 2025-2026 meeting

Each item below shows how the 1,154 asset managers that disclosed a Elevance Health, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Gail K. Boudreaux

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 177,978,713AGAINST: 1,714,229
Details: description as filed, official tally, votes by 200 asset managers

Description as filed by funds: Election of Directors: Gail K. Boudreaux

Elevance Health, Inc.’s own tally for this item (“Elect Director: Gail K. Boudreaux”): 177,978,713 for, 1,714,229 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes:”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 200 asset managers below reported 64,429,082 for, 20,522 against, 8,056 abstained, 169 not voted.

FOR
FOR: 64,429,082AGAINST: 20,522ABSTAIN: 8,056NOT VOTED: 169
Largest asset managers voting on “Election of Directors: Gail K. Boudreaux” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,030,83823 10For
BlackRock7,240,6250 00For
Fidelity5,246,5750 00For
FIRST EAGLE FUNDS3,019,7020 00For
Invesco2,644,4400 00For
State Street2,450,75018 00For
T. Rowe Price2,029,4760 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,987,9020 00For
Charles Schwab1,734,5210 00For
MFS1,568,7970 00For
TIAA1,383,3930 00For
Capital Group1,057,8320 00For
John Hancock959,1220 00For
Bridge Builder Trust924,9530 00For
Hartford812,5520 00For
Dimensional790,4710 00For
FRANKLIN MUTUAL SERIES FUNDS700,7040 00For
First Trust597,9110 00For
GMO589,5280 00For
BNY Mellon584,7310 00For
SEQUOIA FUND INC532,4670 00For
Brighthouse512,7100 8,0550For
Jackson National516,8000 00For
Nuveen440,5290 00For
MASTER INVESTMENT PORTFOLIO341,1680 00For

Showing the 25 largest of 200 asset managers. See all 200 in the interactive database.

2. Elect Director: Robert L. Dixon, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 10 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 174,098,489AGAINST: 5,590,793
Details: description as filed, official tally, votes by 200 asset managers

Description as filed by funds: Election of Directors: Robert L. Dixon, Jr.

Elevance Health, Inc.’s own tally for this item (“Elect Director: Robert L. Dixon, Jr.”): 174,098,489 for, 5,590,793 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 200 asset managers below reported 64,401,989 for, 47,615 against, 8,056 abstained, 169 not voted.

FOR
FOR: 64,401,989AGAINST: 47,615ABSTAIN: 8,056NOT VOTED: 169
Largest asset managers voting on “Election of Directors: Robert L. Dixon, Jr.” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,030,78279 10For
BlackRock7,240,6250 00For
Fidelity5,246,5750 00For
FIRST EAGLE FUNDS3,019,7020 00For
Invesco2,644,4400 00For
State Street2,450,73731 00For
T. Rowe Price2,029,4760 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,987,9020 00For
Charles Schwab1,734,5210 00For
MFS1,568,7970 00For
TIAA1,383,3930 00For
Capital Group1,057,8320 00For
John Hancock959,1220 00For
Bridge Builder Trust924,9530 00For
Hartford812,5520 00For
Dimensional790,4710 00For
FRANKLIN MUTUAL SERIES FUNDS700,7040 00For
First Trust597,9110 00For
GMO589,5280 00For
BNY Mellon584,7310 00For
SEQUOIA FUND INC532,4670 00For
Brighthouse512,7100 8,0550For
Jackson National516,8000 00For
Nuveen440,5290 00For
MASTER INVESTMENT PORTFOLIO341,1680 00For

Showing the 25 largest of 200 asset managers. See all 200 in the interactive database.

3. Elect Director: Deanna D. Strable

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 9 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 175,331,822AGAINST: 4,360,980
Details: description as filed, official tally, votes by 198 asset managers

Description as filed by funds: Election of Directors: Deanna D. Strable

Elevance Health, Inc.’s own tally for this item (“Elect Director: Deanna D. Strable”): 175,331,822 for, 4,360,980 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 198 asset managers below reported 64,334,918 for, 42,860 against, 8,056 abstained, 169 not voted.

FOR
FOR: 64,334,918AGAINST: 42,860ABSTAIN: 8,056NOT VOTED: 169
Largest asset managers voting on “Election of Directors: Deanna D. Strable” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,030,79961 10For
BlackRock7,240,6250 00For
Fidelity5,246,5750 00For
FIRST EAGLE FUNDS3,019,7020 00For
Invesco2,644,4400 00For
State Street2,450,7680 00For
T. Rowe Price2,029,4760 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,987,9020 00For
Charles Schwab1,734,5210 00For
MFS1,568,7970 00For
TIAA1,383,3930 00For
Capital Group1,057,8320 00For
John Hancock959,1220 00For
Bridge Builder Trust924,9530 00For
Hartford812,358194 00For
Dimensional790,4710 00For
FRANKLIN MUTUAL SERIES FUNDS700,7040 00For
First Trust597,9110 00For
GMO589,5280 00For
BNY Mellon584,7310 00For
SEQUOIA FUND INC532,4670 00For
Brighthouse512,243467 8,0550For
Jackson National516,8000 00For
Nuveen440,5290 00For
MASTER INVESTMENT PORTFOLIO341,1680 00For

Showing the 25 largest of 198 asset managers. See all 198 in the interactive database.

4. 2. Advisory vote on the Company's executive compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 39 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%
FOR: 172,363,616AGAINST: 7,240,619
Details: description as filed, official tally, votes by 1,152 asset managers

Description as filed by funds: Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").

Elevance Health, Inc.’s own tally for this item (“2. Advisory vote on the Company's executive compensation”): 172,363,616 for, 7,240,619 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Elevance Health, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 193 asset managers voting on “Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,030,77189 20For
BlackRock7,240,6250 00For
Fidelity5,246,5750 00For
FIRST EAGLE FUNDS3,019,7020 00For
Invesco2,644,4400 00For
State Street2,450,7680 00For
T. Rowe Price2,029,4760 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,987,9020 00For
Charles Schwab1,734,5210 00For
MFS1,568,7970 00For
TIAA1,383,3930 00For
Capital Group1,057,8320 00For
John Hancock959,1220 00For
Bridge Builder Trust924,9530 00For
Hartford812,358194 00For
Dimensional790,4710 00For
FRANKLIN MUTUAL SERIES FUNDS700,7040 00For
First Trust597,9110 00For
GMO589,5280 00For
BNY Mellon584,7310 00For
SEQUOIA FUND INC532,4670 00For
Brighthouse512,243467 8,0550For
Jackson National516,117683 00For
Nuveen440,5290 00For
MASTER INVESTMENT PORTFOLIO341,1680 00For

Fund voting reports, all 193 managers: 64,259,138 for, 306,371 against, 8,057 abstained, 170 not voted, 40 mixed. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 995 asset managers voting on “Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock9,885,0196,675 00For
Wellington7,796,6860 00For
State Street6,566,4805,722 00For
T. Rowe Price5,313,7545,217 00For
GEODE CAPITAL MANAGEMENT, LLC5,203,9750 00For
Invesco4,521,3410 00For
HARRIS ASSOCIATES L P4,336,1250 00For
Artisan4,219,6290 00For
First Eagle Investment Management, LLC3,754,4360 00For
Sanders Capital, LLC3,111,9100 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2,649,9970 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC2,039,0830 00For
John Hancock1,959,7190 00For
Nuveen1,958,5570 00For
Northern Trust1,908,9050 00For
Charles Schwab1,773,8730 00For
Grantham, Mayo, Van Otterloo & Co. LLC1,734,7380 00For
Amundi1,615,7144,061 00For
UBS1,487,6880 00For
Ruane, Cunniff & Goldfarb L.P.1,393,9000 00For
Fidelity1,367,7600 00For
Baupost1,275,1540 00For
EAGLE CAPITAL MANAGEMENT LLC1,237,3840 00For
Newton Investment Management North America, LLC1,139,2540 00For
Brave Warrior Advisors, LLC1,128,9870 00For

Institutional-manager reports, all 995 managers: 117,566,229 for, 4,499,275 against, 21,153 abstained, 94,906 not voted. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of the appointment of Ernst & Young LLP

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

90% Approved · of votes cast

FOR 90%
FOR: 175,183,332AGAINST: 19,141,697
Details: description as filed, official tally, votes by 197 asset managers

Description as filed by funds: Ratification of Ernst & Young LLP as Auditors for 2026.

Elevance Health, Inc.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP”): 175,183,332 for, 19,141,697 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based upon the following votes:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Elevance Health, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 197 asset managers below reported 62,613,765 for, 1,763,912 against, 8,056 abstained, 169 not voted.

FOR
FOR: 62,613,765AGAINST: 1,763,912ABSTAIN: 8,056NOT VOTED: 169
Largest asset managers voting on “Ratification of Ernst & Young LLP as Auditors for 2026.” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,178,084852,776 10For
BlackRock7,239,3481,277 00For
Fidelity5,246,5750 00For
FIRST EAGLE FUNDS3,019,7020 00For
Invesco2,644,4400 00For
State Street2,450,73731 00For
T. Rowe Price2,029,4760 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,987,9020 00For
Charles Schwab1,734,5210 00For
MFS1,568,7970 00For
TIAA1,383,3930 00For
Capital Group1,057,8320 00For
John Hancock959,1220 00For
Bridge Builder Trust924,9530 00For
Hartford812,358194 00For
Dimensional790,4710 00For
FRANKLIN MUTUAL SERIES FUNDS700,7040 00For
First Trust597,9110 00For
GMO589,5280 00For
BNY Mellon45,992538,739 00Mixed
SEQUOIA FUND INC532,4670 00For
Brighthouse512,243467 8,0550For
Jackson National353,563163,237 00Mixed
Nuveen440,5290 00For
MASTER INVESTMENT PORTFOLIO341,1680 00For

Showing the 25 largest of 197 asset managers. See all 197 in the interactive database.

6. 4. Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to…

Official resultOTHER SOCIAL ISSUESReported outcome: Not approved

Combines 8 wordings of this item as funds reported it.

9% Not approved · of votes cast

9%AGAINST
FOR: 15,587,160AGAINST: 162,924,290
Details: description as filed, official tally, votes by 198 asset managers

Description as filed by funds: Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax- Exempt Political Groups.

Elevance Health, Inc.’s own tally for this item (“4. Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups”): 15,587,160 for, 162,924,290 against — failed, per its Form 8-K filed May 13, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The shareholder proposal requesting a study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups was not approved based upon the following votes:”
Support: 9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Elevance Health, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Oversee and Report on Independent Study Related to Company's Political Contributions” (6 managers, 4,824 for, 299,054 against); “S/H Proposal - Political/Government” (2 managers, 99 for, 9 against).

The 198 asset managers below reported 431,044 for, 63,617,600 against, 104,710 abstained, 169 not voted.

AGAINST
FOR: 431,044AGAINST: 63,617,600ABSTAIN: 104,710NOT VOTED: 169
Largest asset managers voting on “Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to P” at Elevance Health, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard25,30920,005,538 140Against
BlackRock5,2937,235,332 00Against
Fidelity05,246,575 00Against
FIRST EAGLE FUNDS03,019,702 00Against
Invesco02,644,440 00Against
State Street5912,450,177 00Against
T. Rowe Price02,029,476 00Against
HARRIS ASSOCIATES INVESTMENT TRUST01,987,902 00Against
Charles Schwab01,734,521 00Against
MFS01,568,797 00Against
TIAA01,383,393 00Against
Capital Group01,057,832 00Against
John Hancock0959,122 00Against
Bridge Builder Trust0924,953 00Against
Hartford0812,552 00Against
Dimensional0790,471 00Against
FRANKLIN MUTUAL SERIES FUNDS0700,704 00Against
First Trust0597,911 00Against
GMO0589,528 00Against
BNY Mellon0584,731 00Against
SEQUOIA FUND INC0532,467 00Against
Jackson National0516,800 00Against
Nuveen0440,529 00Against
Brighthouse0418,354 15,1490Against
MASTER INVESTMENT PORTFOLIO0341,168 00Against

Showing the 25 largest of 198 asset managers. See all 198 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 14, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest Elevance Health, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 217,162,380 shares outstanding at the time of that meeting.

Fund voting reports: top Elevance Health, Inc. shareholders by shares voted on “Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 9.22%
2BlackRock 3.33%
3Fidelity 2.42%
4FIRST EAGLE FUNDS 1.39%
5Invesco 1.22%
6State Street 1.13%
7T. Rowe Price 0.93%
8HARRIS ASSOCIATES INVESTMENT TRUST 0.92%
9Charles Schwab 0.80%
10MFS 0.72%
Institutional-manager reports: top Elevance Health, Inc. shareholders by shares voted on “Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 4.55%
2Wellington 3.59%
3State Street 3.03%
4T. Rowe Price 2.45%
5GEODE CAPITAL MANAGEMENT, LLC 2.40%
6Invesco 2.08%
7HARRIS ASSOCIATES L P 2.00%
8Artisan 1.94%
9First Eagle Investment Management, LLC 1.73%
10Sanders Capital, LLC 1.43%

Reported Elevance Health, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Elevance Health, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 9.16% 13F
State Street 4.74% 13F
Wellington Management 3.79% 13F
Invesco 2.22% 13F
T. Rowe Price 2.19% 13F
BNY Mellon 1.31% 13F
Morgan Stanley 1.16% 13F
Northern Trust 0.99% 13F

Percentages above are of 217,162,380 shares outstanding, as reported by Elevance Health, Inc. on its Form 10-Q dated April 15, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Elevance Health, Inc.’s 10-Q dated April 15, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Elevance Health, Inc.'s shareholder meeting held May 13, 2026, in the 2025-2026 proxy season, 1,154 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 7,403 separate fund positions. On the most widely held item on that ballot — Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). — Elevance Health, Inc.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Elevance Health, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2026.

Elevance Health, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.